DALACIN C

Medicinal product

(Invented) name

DALACIN C

Active substance (s)

Klindamicinas

Strength

150 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G01AA10, Clindamycin

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

1994-06-22

Date of renewal

2010-06-15

Documents

2047 Pakuotės lapelis 2024 11 26.docx

2047 DALACIN C PCS PL 2024 11 26.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Klindamicinas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
5195	10488	1010488	lizdinė plokštelė	N16		Receptinis	LT/1/94/2047/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2010-06-15	Perregistruotas
1994-06-22	Registruotas